It was September 2007 when 37-year-old Stephanie Hosford discovered a chickpea-sized lump. (iStock) She didn’t know it yet, but finding a lump in her breast was just the first in a series of life-altering events. It was September 2007 when 37-year-old Stephanie Hosford discovered that chickpea-sized lump. At the time, she and her husband, Grant,… Read More: Pregnant with breast cancer: One woman's incredible story »
Open blockchain jobs are on the rise. In fact, according to a Glassdoor report, the number of unique jobs related to blockchain rose from 446 in August 2017 to 1,775 for the same month this year. That’s an eye-popping 300 percent. Not bad for a new technology. WHY IT MATTERS When blockchain does become widespread… Read More: Top blockchain career opportunities in healthcare »
But you — and the Twitter trolls — may have noticed that Jenner’s skin has done a complete 180 recently. At first, she owned her acne; then, she managed to kick it, leading to headlines that are less “just like us” and more like “glowy” and “radiant.” So what changed? The answer: Christie Kidd, dermatology… Read More: Kendall Jenner's Skin Guru Spills The 5 Tips For Clearing… »
FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer Print this page November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer… Read More: FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell… »